The global sepsis diagnostic market size is expected to reach a value of USD 1.1 billion by 2027, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. High prevalence of sepsis, introduction of technologically advanced medical examination systems and increasing government initiatives is expected to propel market growth over the forecast period.
According to CDC estimates, every year more than 1.7 million adults in U.S. suffer from sepsis, which leads to around 270,000 deaths. Furthermore, according to the report published by OECD in 2018, every year around 3.8 million patients suffer from hospital-acquired infections (HAIs) in acute care hospitals in European countries. High prevalence of HAIs in key regions is expected to significantly increase the demand for medical examination solutions, thereby fueling market growth over the forecast period.
Request a sample Copy of the Global Sepsis Diagnostics Market Research Report @ www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market/request/rs1
Increasing regulatory approval and introduction of technologically advanced medical examination solutions for the life-threatening disease condition are expected to facilitate market growth over the forecast period. In May 2018, T2 Biosystems, Inc., a U.S.-based emerging medical examination solutions company received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens.
In April 2019, the Scottish Government in collaboration with Sepsis Research (originally called FEAT – The Fiona Elizabeth Agnew Trust) launched a Scotland-wide campaign to spread public awareness about the signs and symptoms of sepsis. Such initiatives to raise public awareness about the disease condition is expected to raise demand for its rapid medical examination solutions and support its market growth in the near future.
Further key findings from the report suggest:
Have Any Query? Ask Our Experts @ www.grandviewresearch.com/inquiry/3575/ibb
Grand View Research has segmented the global sepsis diagnostics market on the basis of product, technology, pathogen, testing type, and region:
Sepsis Diagnostics Product Outlook (Revenue, USD Million, 2016 – 2027)
Sepsis Diagnostics Technology Outlook (Revenue, USD Million, 2016 – 2027)
Sepsis Diagnostics Pathogen Outlook (Revenue, USD Million, 2016 – 2027)
Sepsis Diagnostics Testing Type Outlook (Revenue, USD Million, 2016 – 2027)
Sepsis Diagnostics Regional Outlook (Revenue, USD Million, 2016 – 2027)
Browse Related Category @
Ovarian Cancer Diagnostics Market – www.grandviewresearch.com/industry-analysis/ovarian-cancer-diagnostics-market
Malaria Diagnostics Market – www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research Guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market